Authors: Verburg, RJ Kruize, AA van den Hoogen, FHJ Fibbe, WE Petersen, EJ Preijers, F Sont, JK Barge, RMY Bijlsma, JWJ van de Putte, LB Breedveld, FC van Laar, JM

Citation: Rj. Verburg et al., High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy, ARTH RHEUM, 44(4), 2001, pp. 754-760

Authors: van der Griend, R Verdonck, LF Petersen, EJ Veenhuizen, P Bloem, AC Lokhorst, HM

Citation: R. Van Der Griend et al., Donor leukocyte infusions inducing remissions repeatedly in a patient withrecurrent multiple myeloma after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 195-197

Authors: Petersen, EJ Irish, SM Lyons, CL Miklaski, SF Bryan, JM Henderson, NE Masullo, LN

Citation: Ej. Petersen et al., Reliability of water volumetry and the figure of eight method on subjects with ankle joint swelling, J ORTHOP SP, 29(10), 1999, pp. 609-615

Authors: Cornelissen, JJ Fibbe, WE Schattenberg, AVMB Petersen, EJ Willemze, R de Witte, TJM Lijwenberg, B Verdonck, LF Van der Biezen, A Brand, R

Citation: Jj. Cornelissen et al., A retrospective Dutch study comparing T-cell depleted allogeneic blood stem cell transplantation vs T-cell depleted allogeneic bone marrow transplantation, TRANSFUS SC, 19(3), 1998, pp. 196-197

Authors: Verdonck, LF Petersen, EJ Lokhorst, HM Nieuwenhuis, HK Dekker, AW Tilanus, MGJ de Weger, RA

Citation: Lf. Verdonck et al., Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells, BONE MAR TR, 22(11), 1998, pp. 1057-1063